Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GSK PLC Sponsored ADR stock logo
GSK
GSK
$50.38
-0.2%
$55.25
$35.45
$61.69
$102.47B0.384.28 million shs2.41 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$221.17
-0.6%
$237.59
$146.12
$251.71
$535.63B0.277.86 million shs5.46 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.65
-3.1%
$27.14
$21.97
$28.75
$150.92B0.3536.09 million shs37.42 million shs
5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GSK PLC Sponsored ADR stock logo
GSK
GSK
-0.17%-3.65%-9.51%-16.05%+36.04%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-0.93%-3.38%-6.75%-7.46%+41.43%
Pfizer Inc. stock logo
PFE
Pfizer
-0.12%-1.00%-2.28%-2.80%+16.24%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GSK PLC Sponsored ADR stock logo
GSK
GSK
$50.38
-0.2%
$55.25
$35.45
$61.69
$102.47B0.384.28 million shs2.41 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$221.17
-0.6%
$237.59
$146.12
$251.71
$535.63B0.277.86 million shs5.46 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.65
-3.1%
$27.14
$21.97
$28.75
$150.92B0.3536.09 million shs37.42 million shs
5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GSK PLC Sponsored ADR stock logo
GSK
GSK
-0.17%-3.65%-9.51%-16.05%+36.04%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-0.93%-3.38%-6.75%-7.46%+41.43%
Pfizer Inc. stock logo
PFE
Pfizer
-0.12%-1.00%-2.28%-2.80%+16.24%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GSK PLC Sponsored ADR stock logo
GSK
GSK
1.90
Reduce$53.005.20% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.67
Moderate Buy$252.4814.15% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.23
Hold$28.7412.05% Upside

Current Analyst Ratings Breakdown

Latest PFE, JNJ, and GSK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
UpgradeHold (C-)Hold (C)
5/1/2026
GSK PLC Sponsored ADR stock logo
GSK
GSK
UpgradeHold (C+)Buy (B)
4/29/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetNeutral$26.00 ➝ $27.00
4/24/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
DowngradeBuy (B+)Buy (B)
4/20/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetBuy$244.00 ➝ $266.00
4/20/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingUnderperform$25.00
4/16/2026
Pfizer Inc. stock logo
PFE
Pfizer
Initiated CoverageOutperform$33.00
4/16/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetBuy$240.00 ➝ $275.00
4/16/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetOutperform$237.00 ➝ $246.00
4/15/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Set Price Target$283.00
4/15/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Reiterated RatingOutperform$265.00
(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GSK PLC Sponsored ADR stock logo
GSK
GSK
$43.07B2.37$5.99 per share8.41$11.57 per share4.35
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$94.19B5.65$14.03 per share15.76$33.73 per share6.56
Pfizer Inc. stock logo
PFE
Pfizer
$62.58B2.34$4.26 per share6.02$15.86 per share1.62
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GSK PLC Sponsored ADR stock logo
GSK
GSK
$7.54B$3.8513.099.822.5617.82%44.28%11.49%N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$26.80B$8.6525.5717.582.1821.83%32.60%13.29%7/15/2026 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$1.3119.588.97N/A11.83%19.44%8.41%N/A

Latest PFE, JNJ, and GSK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/5/2026Q1 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7220$0.75+$0.0280$0.47$13.84 billion$14.45 billion
4/14/2026Q1 2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.68$2.70+$0.02$2.14$23.60 billion$24.06 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
GSK PLC Sponsored ADR stock logo
GSK
GSK
$1.883.73%-7.86%48.83%N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.202.35%+5.25%60.12%64 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.71%-13.20%131.30%16 Years

Latest PFE, JNJ, and GSK Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/29/2026
GSK PLC Sponsored ADR stock logo
GSK
GSK
quarterly$0.443.36%5/15/20265/15/20267/9/2026
4/22/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.436.71%5/8/20265/8/20266/12/2026
4/14/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.342.23%5/26/20265/26/20266/9/2026
1/1/2100
GSK PLC Sponsored ADR stock logo
GSK
GSK
quarterly$0.42064.3%8/15/20258/15/202510/9/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GSK PLC Sponsored ADR stock logo
GSK
GSK
0.80
0.79
0.52
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.46
1.03
0.77
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.25
0.87

Institutional Ownership

CompanyInstitutional Ownership
GSK PLC Sponsored ADR stock logo
GSK
GSK
15.74%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
GSK PLC Sponsored ADR stock logo
GSK
GSK
10.00%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
CompanyEmployeesShares OutstandingFree FloatOptionable
GSK PLC Sponsored ADR stock logo
GSK
GSK
66,8412.03 billion1.83 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,2002.41 billion2.40 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable

Recent News About These Companies

Pfizer (PFE) Gets a Buy from Argus Research
Pfizer (NYSE:PFE) Stock Price Down 3.1% - Time to Sell?
GLP-1 battle heats up between Eli Lilly and Novo Nordisk
Pfizer (PFE) Receives a Buy from Scotiabank
Pfizer Sees Unusually High Options Volume (NYSE:PFE)
Pfizer Inc. $PFE Shares Purchased by Swedbank AB

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
GSK stock logo

GSK NYSE:GSK

$50.38 -0.12 (-0.23%)
Closing price 03:59 PM Eastern
Extended Trading
$50.38 -0.01 (-0.01%)
As of 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$221.17 -1.34 (-0.60%)
Closing price 03:59 PM Eastern
Extended Trading
$221.25 +0.08 (+0.04%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Pfizer stock logo

Pfizer NYSE:PFE

$25.65 -0.83 (-3.15%)
Closing price 03:59 PM Eastern
Extended Trading
$25.68 +0.03 (+0.11%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.